Immunotherapy is the new frontier in cancer medicine. It has emerged as a way to harness your own body to defeat cancer and generate a long-lasting response. Most of these therapies involve unleashing the T Cells to attack cancer cells, and early successes have shown great results for certain cancers.
Electrochemotherapy (ECT) is another important breakthrough in treating cancer tumors. ECT delivers short bursts of electricity to a tumor that makes the tumor porous and dramatically increases the absorption of chemotherapy drugs. The electrical pulse has also been shown to spark an immune engagement against cancer.
Driven by these innovations, the industry is expected to witness a market growth of $2.21 billion this year.
To put the spotlight on other key developments, Healthcare Tech Outlook illustrates how the oncology sector is significantly advancing. This edition also features thought leadership articles from Derya DİLEK KANÇAĞI, PhD, Laboratory Manager, Acıbadem Labcell Cellular Therapy Center; Mike Koroscik, Vice President of Oncology, Allina Health; and Douglas Braun, Senior Pharmacy Director, American Oncology Network.
In this edition of Healthcare Tech Outlook, we also bring to you the story of some of the top oncology solution providers. In the list, Merit Medical particularly stands out for its proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The list also comprises Jasper Health for its personalized care and comprehensive support through one-on-one coaching, and OncoGenesis for its simplified cervical screening process.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the oncology space.
We would like to know your thoughts.















